MMSL 2013, 82(1):2-24 | DOI: 10.31482/mmsl.2013.001
BINDING OF QUATERNARY AMMONIUM SALTS TO ACETYLCHOLINE RECEPTORS: POSSIBLE CHEMICAL WARFARE NERVE AGENTSReview article
- 1083 Jewell Road, Milan, MI 48160, USA
Classical chemical nerve agents are organophosphate based compounds such as Sarin, Soman, Tabun, VX and others. These compounds inhibit acetylcholinesterases in the synapses of nerve junctions. Instead of inactivating acetylcholinesterases, compounds, quaternary amines, can block nerve transmission by binding primarily to the acetylcholine receptor sites. The U.S. Patent Office has published 23 unique patents or invention registrations on the synthesis of compounds that can bind to muscarinic and nicotinic acetylcholine receptors. It is likely that some of these compounds could serve as either polarizing or nonpolarizing nerve agents that bind to the acetylcholine receptor and block binding of acetylcholine. This paper has systematically reviewed a series of bisquaternary amines that could be potentially deadly nerve agents. Analogous tertiary amines, based on the structure of the parent bisquaternary amines, have been proposed as compounds that might be more soluble in membranes making them more bioavailable and toxic. Finally, methods have been discussed that could identify this class of compounds using a bioassay for binding to the acetylcholine receptor. A tool in the identification of these compounds, the Hofmann elimination reaction, has been proposed as a novel method for helping to establish that quaternary or tertiary amines are functional groups of the nerve agent.
Keywords: Quaternary ammonium salts; nerve agents; chemical warfare; acetylcholine receptor
Received: January 22, 2013; Revised: February 12, 2013; Published: March 8, 2013 Show citation
References
- Conti-Tronconi, B. M.; Raftery, M. A., Nicotinic acetylcholine receptor contains multiple binding sites: evidence from binding α-dendrotoxin. Proc. Natl. Acad. Sci. 1986, 83, 6646-6650. Go to original source... Go to PubMed...
- Sobell, H. M.; Sakore, T. D.; Tavale, S. S.; Canepa, F. G.; Pauling, P.; Petcher, T. J., Stereochemistry of a curare alkaloid: O,O', N-trimethyl-d-tubocurarine. Proc. Nat. Acad. Sci. 1972, 69, 2212-2215. Go to original source... Go to PubMed...
- Raghavendra, T., Neuromuscular blocking drugs: discovery and development. J. Royal Soc. Med. 2002, 95, 363-367. Go to original source... Go to PubMed...
- Kuca, K.; Hrabinova, M.; Soukup, O.; Tobin, G.; Karasova, J.; Pohanka, M. Pralidoxime-the gold standard of acetylcholinesterase reactivators - reactivation in vitro efficacy. Bratisl. Lek. Listy. 2010, 111, 502-504. Go to PubMed...
- Lee, C.; Jones, T., Molecular conformation-activity relationship of decamethonium congeners. Br. J. Anaesth. 2002, 88, 692-699. Go to original source... Go to PubMed...
- Paxman, J.; Harris, R. A., Higher Form of Killing: The Secret History of Chemical and Biological Warfare. Hill and Wang, New York 1982, pp. 53-67.
- Mumford, H. E.; Price, M., Lenz, D. E.; Cerasoli, D. M. Post-exposure therapy with human butyrylcholinesterase following percutaneous VX challenge in guinea-pigs. Clin. Toxicol. 2011, 49, 287-97. Go to original source... Go to PubMed...
- Sommer, H. Z.; Wicks, G. E. Jr.; Owens, O. O. Chemical agents. U.S. Patent 4,246,416, 1981.
- Sommer, H. Z.; Owens, O. O. Chemical agents. U.S. Patent 4,686,293, 1987.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,241,212, 1980.
- Sommer, H. Z.; Wicks, G. E., Jr. Unsymmetrical pyrrolino benzyl quaternary compounds. U.S. Patent 4,240,965, 1980.
- Sommer, H. Z.; Wicks, G. E., Jr.; Owens, O. O. Ketobenzylcarbamates. U.S. Patent 4,677,222, 1987.
- Sommer, H. Z.; Owens, O. O. Chemical agents. U.S. Invention Registration H443, 1988.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,672,123, 1987.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,672,124, 1987.
- Sommer, H. Z.; Wicks, G. E., Jr. Picolyl unsymmetrical bis-quaternary carbamates. U.S. Patent 4,246,415, 1981.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,241,210, 1980.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,672,119, 1987.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patents 4,672,122, 1987.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,672,069, 1987.
- Sommer, H. Z.; Krenzer, J.; Owens, O. O.; Miller, J. L. Chemical agents. U.S. Patent 4,677,204, 1987.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,241,218, 1980.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,241,211, 1980.
- Sommer, H. Z.; Wicks, G. E., Jr.; Witten, B. Chemical agents. U.S. Patent 4,672,120, 1987.
- Sommer, H. Z.; Chemical agents. U.S. Patent 4,692,530, 1987.
- Sommer, H. Z.; Owens, O. O.; Miller, J. L. Isoquinilinium chemical agents. U.S. Patent 4,673,745, 1987.
- Sommer, H. Z.; Wicks, G. E., Jr. Unsymmetrical bis-quaternary amino acids. U.S. Patent 4,246,418, 1981.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agents. U.S. Patent 4,241,209, 1980.
- Sommer, H. Z.; Wicks, G. E., Jr. Chemical agent. U.S. Patent 4,677,205, 1987.
- Sommer, H. Z.; Miller, J. L. Haloalkyl-carbamoxyalkyl derivatives. U.S. Patent 3,956,365, 1976.
- Sommer, H. Z.; Miller, J. L. Hydroxyquinuclidine derivatives. U.S. Patent 3,919,241, 1975.
- Sommer, H. Z.; Miller, J. L. Chemical agents. U.S. Patent 4,675,411, 1987.
- Physical properties of 1,9-decadiene http://www.sigmaaldrich.com/catalog/ProductDetail.do?D7=0&N5=Product%20No.%7CBRAND_KEY&N4=347841%7CAldrich&N25=0&QS=ON&F=SPEC
- Library of Congress, Thomas, Chemical Weapons Convention, Treaty Number 103-21, ratified April 12, 1997.
- ACS, American Chemical Society, January 2012, The Journal of Organic Chemistry Guidelines for Authors http://pubs.acs.org/paragonplus/submission/joceah/joceah_authguide.pdf
- Geoghegan, J.; Tong, J. L. Chemical warfare agents. Contin. Educ. Anaesth. Crit. Care Pain. 2006, 6, 230-234. Go to original source...
- Savulescu, J.; Spriggs, M. Current controversy: The hexamethonium asthma study and the death of a normal volunteer in research. J. Med. Ethics. 2002, 28, 3-4. Go to original source... Go to PubMed...
- Beers, W. H.; Reich, E. Structure and activity of acetylcholine. Nature. 1970, 228(5), 917-922. Go to original source... Go to PubMed...
- Zhang Z.; Zheng G.; Pivavarchyk M.; Deaciuc A. G.; Dwoskin L. P.; Crooks P.A. Novel bis, tris-, and tetrakis-tertiary amino analogs as antagonists at neuronal nicotinic receptors that mediate nicotine-evoked dopamine release. Bioorg. Med. Chem. Lett. 2011, 21, 88-91. Go to original source... Go to PubMed...
- 3-Quinuclidnyl benzilate; Expert Meeting: Incapacitating Chemical Agents: Implications for International Law, Montreux, Switzerland, March 2010 87 pp.http://www.icrc.org/eng/assets/files/publications/icrc-002-4051.pdf
- Kawai, H.; Carlson, B. J.; Okita, D. K.; Raftery, M. A. Eserine and other tertiary amine interactions with Torpedo acetylcholine receptor postsynaptic membrane vesicles. Biochemistry. 1999, 38, 134-141. Go to original source... Go to PubMed...
- Baenziger, J. E.; Ryan, S. E.; Goodreid, M. M.; Vuong, N. Q.; Sturgeon, R. M.; daCosta, C. J. B. Lipid composition alter drug action at the Nicotinic Acetylcholine Receptor. Mol. Pharmacol. 2008, 73, 880-890. Go to original source...
- Welch, R. M.; Brown, A.; Ravitch, J.; Dahl, R. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma. Clin. Pharmacol. Ther. 1995, 58, 132-142. Go to original source... Go to PubMed...
- Zobov, V. V.; Aslyamova, A. A.; Berezinsky, L. A.; Reznik, V. S.; Akamsin, V. D.; Galyametdinova, I. V.; Nafikova, A. A. Synthesis and biological activity of α, ω-bis(ammonio)alkalis containing oxopyrimidinyl radicals. Pharm. Chem. J. 2004, 38, 540-544. Go to original source...